VANDA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 31 Mar 2023)
What this means for you
Registered since 13 Jun 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal was filed 15 Sept 2026 and is awaiting the USPTO's acceptance).
Record
- Serial number
- 87230729
- Registration number
- 5222952
- Mark type
- Word mark
- Filed
- 08 Nov 2016
- Published for opposition
- 28 Mar 2017
- Registered
- 13 Jun 2017
- Next maintenance filing
- §8 & §9 renewal, filed 15 Sept 2026 — awaiting the USPTO's acceptance
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in the treatment of schizophrenia; pharmaceutical preparations containing iloperidone; pharmaceutical preparations and substances for use in the treatment of circadian rhythm diseases and disorders; pharmaceutical preparations and substances for use in the treatment of non-24 hour sleep/wake disorder; and pharmaceutical preparations containing tasimelteon
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
Prior registrations
Prosecution history
- 15 Sept 2026 — TEAS SECTION 8 & 9 RECEIVED
- 13 Jun 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 31 Mar 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 31 Mar 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 30 Mar 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Sept 2022 — TEAS SECTION 8 & 15 RECEIVED
- 13 Jun 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 13 Jun 2017 — REGISTERED-PRINCIPAL REGISTER
- 28 Mar 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Mar 2017 — PUBLISHED FOR OPPOSITION
- 08 Mar 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Feb 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Feb 2017 — ASSIGNED TO EXAMINER
- 14 Nov 2016 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Nov 2016 — NEW APPLICATION ENTERED